Alfresa Holdings (2784) Stock Overview
Through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
2784 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Alfresa Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,273.50 |
| 52 Week High | JP¥2,315.00 |
| 52 Week Low | JP¥1,897.00 |
| Beta | -0.18 |
| 1 Month Change | 7.29% |
| 3 Month Change | 3.08% |
| 1 Year Change | 3.20% |
| 3 Year Change | 39.31% |
| 5 Year Change | 9.94% |
| Change since IPO | 149.15% |
Recent News & Updates
Does Alfresa Holdings (TSE:2784) Have A Healthy Balance Sheet?
Oct 01
Alfresa Holdings' (TSE:2784) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 24Recent updates
Does Alfresa Holdings (TSE:2784) Have A Healthy Balance Sheet?
Oct 01Alfresa Holdings' (TSE:2784) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 24Alfresa Holdings (TSE:2784) Is Increasing Its Dividend To ¥34.00
Jul 09Alfresa Holdings' (TSE:2784) Returns Have Hit A Wall
May 18Is Now The Time To Put Alfresa Holdings (TSE:2784) On Your Watchlist?
Apr 11Alfresa Holdings Corporation's (TSE:2784) Price Is Right But Growth Is Lacking
Mar 06Investors Could Be Concerned With Alfresa Holdings' (TSE:2784) Returns On Capital
Feb 03Does Alfresa Holdings (TSE:2784) Have A Healthy Balance Sheet?
Jan 10Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations
Nov 21Here's What Analysts Are Forecasting For Alfresa Holdings Corporation (TSE:2784) After Its Half-Year Results
Nov 11Does Alfresa Holdings (TSE:2784) Deserve A Spot On Your Watchlist?
Oct 22The Returns On Capital At Alfresa Holdings (TSE:2784) Don't Inspire Confidence
Oct 08Investor Optimism Abounds Alfresa Holdings Corporation (TSE:2784) But Growth Is Lacking
Jul 30Alfresa Holdings (TSE:2784) Seems To Use Debt Rather Sparingly
Jul 12We Ran A Stock Scan For Earnings Growth And Alfresa Holdings (TSE:2784) Passed With Ease
Jun 25Alfresa Holdings (TSE:2784) Will Be Looking To Turn Around Its Returns
Jun 06Alfresa Holdings' (TSE:2784) Earnings Offer More Than Meets The Eye
May 22Is There An Opportunity With Alfresa Holdings Corporation's (TSE:2784) 32% Undervaluation?
Apr 19Alfresa Holdings' (TSE:2784) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 12Alfresa Holdings' (TSE:2784) Dividend Will Be Increased To ¥35.00
Feb 27Shareholder Returns
| 2784 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 4.8% | 1.6% | 0.5% |
| 1Y | 3.2% | 6.0% | 20.3% |
Return vs Industry: 2784 underperformed the JP Healthcare industry which returned 6% over the past year.
Return vs Market: 2784 underperformed the JP Market which returned 20.3% over the past year.
Price Volatility
| 2784 volatility | |
|---|---|
| 2784 Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in JP Market | 7.9% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 2784 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2784's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 12,452 | Ryuji Arakawa | www.alfresa.com |
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products.
Alfresa Holdings Corporation Fundamentals Summary
| 2784 fundamental statistics | |
|---|---|
| Market cap | JP¥413.14b |
| Earnings (TTM) | JP¥24.85b |
| Revenue (TTM) | JP¥3.03t |
Is 2784 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2784 income statement (TTM) | |
|---|---|
| Revenue | JP¥3.03t |
| Cost of Revenue | JP¥2.82t |
| Gross Profit | JP¥217.37b |
| Other Expenses | JP¥192.52b |
| Earnings | JP¥24.85b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 10, 2026
| Earnings per share (EPS) | 136.72 |
| Gross Margin | 7.16% |
| Net Profit Margin | 0.82% |
| Debt/Equity Ratio | 6.1% |
How did 2784 perform over the long term?
See historical performance and comparisonDividends
Does 2784 pay a reliable dividends?
See 2784 dividend history and benchmarks| Alfresa Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2025 |
| Dividend Pay Date | Dec 05 2025 |
| Days until Ex dividend | 45 days |
| Days until Dividend pay date | 22 days |
Does 2784 pay a reliable dividends?
See 2784 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/12 21:22 |
| End of Day Share Price | 2025/11/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alfresa Holdings Corporation is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Toshihide Yoda | Barclays |
| Ritsuo Watanabe | BofA Global Research |
| Miyabi Yamakita | Jefferies LLC |